Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MasterCard Inc (MA) vs Revvity Inc (RVTY) Price & Performance

MasterCard IncTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

MasterCard Inc vs Revvity Inc — how do they compare? MasterCard Inc trades at $542.37 (market cap $483.71B), while Revvity Inc trades at $110.29 (market cap $11.87B). The key difference: MasterCard Inc is far larger — about 40.8× Revvity Inc's market cap, and MasterCard Inc pays the higher dividend (0.64%). Which is the better fit depends on your goals.

MARVTY
Market Cap
$483.71B$11.87B
Volume
4,635,698
Sector
Consumer CyclicalTechnology
52-Week High
$598.96$117.75
52-Week Low
$471.55$82.26
Enterprise Value
$494.45B$14.36B
Dividend Yield
0.64%0.26%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MasterCard Inc

Mastercard (MA) trades at $541.40, down 0.4% on the day, with a bullish technical outlook supported by moving averages and strong institutional buying. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $4.60 exceeding the $4.41 estimate. Revenue growth remains solid, climbing to $32.79 billion in 2025, while maintaining high net income margins above 45%. Recent news highlights Mastercard's AI initiatives in ASEAN and commitment to financial inclusion, targeting 500 million more underbanked individuals by 2030.

The investment outlook is positive, driven by consistent earnings outperformance, expanding profit margins, and a dominant market position. Risks include competitive pressures from emerging payment technologies like stablecoins and elevated valuation multiples. Analyst consensus is strongly bullish with a $634.27 price target, suggesting ~17% upside from current levels. Institutional accumulation continues, though investors should monitor execution on growth initiatives and macroeconomic impacts on consumer spending.

Revvity Inc

RVTY trades at $106.44, down 3.37% today, but maintains a bullish technical outlook with strong analyst support. The company has consistently beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected on August 4, 2026. Recent developments include AI integration partnerships and FDA clearances, supporting growth in its diagnostics and life sciences segments. Valuation metrics show a P/E of 52.96 and P/S of 4.35, reflecting premium pricing for its growth prospects.

The stock presents a balanced opportunity with analyst consensus pointing to 4.7% upside to the $111.43 price target. Strong institutional ownership and zero sell ratings indicate confidence, though high valuation multiples and negative cash flow trends pose risks. Earnings momentum from recent beats and strategic AI expansions provide catalysts, but investors should monitor margin pressures and China market exposure highlighted in recent quarters.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About MasterCard Inc

Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.

Read more on MA

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY